Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic MelanomaAmod A. Sarnaik, Jason Chesney|Journal of Clinical Oncology|2021Cited by 398
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 studyJason Chesney, Amod A. Sarnaik|Journal for ImmunoTherapy of Cancer|2022Cited by 305